We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · June 20, 2021

Safety and Efficacy of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets

Diabetes Care

 

Additional Info

Diabetes Care
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Diabetes Care 2021 Jun 07;[EPub Ahead of Print], SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, DW Hansen, IB Hirsch, AL Carlson, RM Bergenstal, JL Sherr, SN Mehta, LM Laffel, VN Shah, A Bhargava, RS Weinstock, SA MacLeish, DJ DeSalvo, TC Jones, G Aleppo, BA Buckingham, TT Ly, Omnipod 5 Research Group

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading